Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, moderates this series of 6, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatment targets—and describe the key features of thyroid eye disease and how they are different from other diseases of the eye. Faculty explore the role of nonpharmacologic, pharmacologic, and surgical options for thyroid eye disease and discuss how to implement strategies that help patients with thyroid eye disease improve their quality of life.

This program is also available as a podcast.  You may download it here: https://anchor.fm/ThyroidEyeDisease

Presenting Faculty

• 

  Kimberly Cockerham, MD

  Adjunct Clinical Associate Professor
  Stanford Department of Ophthalmology
  Central Valley Eye Medical Group
  Modesto, California

• 

  Raymond Douglas, MD, PhD

  Professor of Surgery
  Division of Ophthalmology
  Director, Orbital and Thyroid Eye Disease Program
  Cedars-Sinai Medical Center
  Los Angeles, California

• 

  Wendy W. Lee, MD, MS

  Professor of Clinical Ophthalmology and Dermatology
  Director of the Bascom Palmer Aesthetics Center
  Bascom Palmer Eye Institute
  University of Miami Miller School of Medicine
  Miami, Florida

• 

  Terry J. Smith, MD

  Frederick G.L. Huetwell Professor of Ophthalmology and Visual Sciences
  Professor, Department of Internal Medicine
  Kellogg Eye Center
  Ann Arbor, Michigan